Evidence map›Paper›PMID 30670974›Full record

ArticleFrontiers in pharmacology2018

The Protective Effects of Ciji-Hua'ai-Baosheng II Formula on Chemotherapy-Treated H

Biqian Fu, Shengyan Xi, Yanhui Wang, Xiangyang Zhai, Yanan Wang, Yuewen Gong, Yangxinzi Xu, Jiaqi Yang, Yingkun Qiu, Jing Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity.Evidence-based complementary and alternative medicine : eCAM · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Biqian FuDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Shengyan XiDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Yanhui WangDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Xiangyang ZhaiDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Yanan WangDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Yuewen GongCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Yangxinzi XuDepartment of Physiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Jiaqi YangCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Yingkun QiuSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Jing WangSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Dawei LuDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Shuqiong HuangDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Xiamen University · CNUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciji-Hua'ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H

Indexed as

BaxBcl-2caspase-3caspase-8caspase-9chemotherapyCiji-Hua’ai-Baosheng II FormulaH22 hepatocellular carcinoma

Identifiers

PMID30670974
PMCPMC6331466
OpenAlexW2903913916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.